Evidence map›Paper›PMID 20023035›Full record

ArticleJournal of bacteriology2010

MreB drives de novo rod morphogenesis in Caulobacter crescentus via remodeling of the cell wall.

Constantin N Takacs, Sebastian Poggio, Godefroid Charbon, Mathieu Pucheault, Waldemar Vollmer, Christine Jacobs-Wagner

Abstract read
In one paragraph

Article in Journal of bacteriology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 115 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Novel MreB inhibitors with antibacterial activity against Gram (-) bacteria.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Constantin N TakacsDepartment of Molecular, Cellular and Developmental Biology, Yale University, New Haven, Connecticut 06520, USA.
Sebastian Poggio
Godefroid Charbon
Mathieu Pucheault
Waldemar Vollmer
Christine Jacobs-Wagner
Yale University · USHoward Hughes Medical Institute · USNewcastle University · GB

Funding

Temporal and Spatial Control of the Cell Cycle in Caulobacter CrescentusR01GM065835 · NIGMS · YALE UNIVERSITY · PI JACOBS-WAGNER, CHRISTINE · 2003 to 2016
$3.7M
Intermediate filament cytoskeleton and cell shape in Caulobacter crescentusR01GM076698 · NIGMS · YALE UNIVERSITY · PI JACOBS-WAGNER, CHRISTINE · 2006 to 2009
$1.1M
Howard Hughes Medical InstituteNIGMS NIH HHS GM065835NIGMS NIH HHS GM076698NIGMS NIH HHS R01 GM065835NIGMS NIH HHS R01 GM076698
6 · The paper itself

Abstract

MreB, the bacterial actin-like cytoskeleton, is required for the rod morphology of many bacterial species. Disruption of MreB function results in loss of rod morphology and cell rounding. Here, we show that the widely used MreB inhibitor A22 causes MreB-independent growth inhibition that varies with the drug concentration, culture medium conditions, and bacterial species tested. MP265, an A22 structural analog, is less toxic than A22 for growth yet equally efficient for disrupting the MreB cytoskeleton. The action of A22 and MP265 is enhanced by basic pH of the culture medium. Using this knowledge and the rapid reversibility of drug action, we examined the restoration of rod shape in lemon-shaped Caulobacter crescentus cells pretreated with MP265 or A22 under nontoxic conditions. We found that reversible restoration of MreB function after drug removal causes extensive morphological changes including a remarkable cell thinning accompanied with elongation, cell branching, and shedding of outer membrane vesicles. We also thoroughly characterized the composition of C. crescentus peptidoglycan by high-performance liquid chromatography and mass spectrometry and showed that MreB disruption and recovery of rod shape following restoration of MreB function are accompanied by considerable changes in composition. Our results provide insight into MreB function in peptidoglycan remodeling and rod shape morphogenesis and suggest that MreB promotes the transglycosylase activity of penicillin-binding proteins.

Indexed as

Bacterial ProteinsCaulobacter crescentusCell WallCytoskeletonHydrogen-Ion ConcentrationThiourea2,6-dichlorobenzylthiopseudourea4-chlorobenzyl carbamimidothioateBacterial ProteinsThiourea

Identifiers

PMID20023035
PMCPMC2832515
OpenAlexW2083157138

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.